Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lower Profits, Sales, and Trust Weigh on the Dow: Caterpillar Inc. (CAT) and More

The number of housing starts in January fell by 8.5%, way more than economists had been expecting. Additionally, confidence levels among homebuilders also dropped for the first time in almost a year. After that disappointing housing news was released today, all the major indexes began trading lower. As of 12:45 p.m. EST. the Dow Jones Industrial Average is down 20 points, or 0.15%, to 14,015. The S&P 500 and the NASDAQ are both performing slightly worse, down 0.42% and 0.59%, respectively.

Caterpillar Inc. (NYSE:CAT)So who’s down and why?
For the second day in a row, shares of UnitedHealth Group Inc. (NYSE:UNH) are down 1.7%. The continuous slide owes to the profit warning Humana released yesterday. Due to the government’s proposed 2014 Medicare Advantage rates, which Humana claims are too low, the company is projecting that its profit will take a hit next year. The proposed rate change will affect not only Humana but the whole health insurance industry, which includes UnitedHealth, the largest U.S. health-insurer.

Caterpillar Inc. (NYSE:CAT) has lost 1.6% after the company announced that global retail machine sales dropped 4% during November, December, and January after falling just 1% in the three months ending in December. North American sales fell by 11%, while the Asia-Pacific region saw sales drop by 12%. Latin America increased by 3%, and the Europe, Africa, and Middle East region rose by 1%.

Shares of JPMorgan Chase & Co. (NYSE:JPM) are down 0.9% after a group of investors filed a proposal to split the CEO and chairman positions. Jamie Dimon currently holds both positions, but some investors believe he is unable to restore confidence in the bank and ensure future regulatory compliance. These concerns stem from the London Whale scandal and regulatory sanctions the company has faced in recent months. Shareholders will vote on the proposal in May during the company’s annual shareholder meeting.

The article Lower Profits, Sales, and Trust Weigh on the Dow originally appeared on and is written by Matt Thalman.

Fool contributor Matt Thalman owns shares of JPMorgan Chase & Co (NYSE:JPM). Follow Matt on Twitter @mthalman5513. The Motley Fool recommends UnitedHealth Group (NYSE:UNH). The Motley Fool owns shares of JPMorgan Chase & Co.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!